Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta vs Tarceva in Pretreated Advanced NSCLC
NCT00440414Phase 3Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Apr 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed, erlotinib in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Apr 2006; status: completed.
02
Drugs
pemetrexederlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00440414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440414.